SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 23, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight • Neutral

This cluster is too small to warrant a trading signal. Monitor the next earnings release for any fundamental catalyst; insider activity at these levels is noise for a $2B biotech.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$27.29
T+0 close · Apr 22, 2026 · via day close
Latest settled
+22.94%
T+60 · $33.55
Vs SPY
+17.92%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 23 $27.29entry
  2. T+1 · 7mo ago +4.91%α +4.13% · $28.63
  3. T+5 · 7mo ago +13.63%α +12.15% · $31.01
  4. T+20 · 6mo ago +7.92%α +3.28% · $29.45
  5. T+60 · 4mo ago +22.94%α +17.92% · $33.55
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Pharvaris insiders sold a total of $118K in stock over a one-week window, with the Chief Medical Officer accounting for the bulk ($112K) via option exercises and same-day sales. The dollar amount is trivial relative to the $2.0B market cap (0.006%), making this a routine cluster with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$118.0K
Insiders
3

Key Facts

  • Three insiders sold shares totaling $118K from April 22-29, 2026
  • Chief Medical Officer Lu Peng sold $112K via option exercise and same-day open-market sale
  • Total cluster value is 0.006% of Pharvaris' $2.0B market cap
  • Chief Early Development Officer and a Director each sold $3K, de minimis amounts
  • All sales were pre-planned or routine; no insider buying in the cluster

Financial Impact

Insider sales of $118K represent 0.006% of market cap, immaterial

insider holdings

Risk Factors

  • No material risk identified from this cluster alone
  • If a larger insider sale cluster emerges (>$1M or >0.1% of market cap), it would warrant attention

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
84% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1777677017703

Track record

51 reports on PHVS

Performance horizon

15 of 18 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 19 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
  3. Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  4. Nov 12, 20264d ago 6-K Neutral 4/10 No price data
  5. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  6. Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
  7. Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  8. Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  9. Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
  10. Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
Showing 10 of 51

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026